What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally

Focused on cancer therapies, this Boulder-based biotech reported significant insider selling amid a year of sharp share price gains.

CryptoAlerta — análise de criptomoedas e mercado em tempo real